Using yeast modeling, a team from Memorial Sloan-Kettering Cancer Center and elsewhere took a closer look at cancer-related mutations identified through the center's MSKCC IMPACT clinical sequencing program, particularly those affecting genes involved in a Mre11 complex contributing to DNA damage response.